Gustafsson, Nina M. S.
Färnegårdh, Katarina
Bonagas, Nadilly
Ninou, Anna Huguet
Groth, Petra
Wiita, Elisee
Jönsson, Mattias
Hallberg, Kenth http://orcid.org/0000-0002-1268-3844
Lehto, Jemina http://orcid.org/0000-0002-2827-5749
Pennisi, Rosa
Martinsson, Jessica
Norström, Carina
Hollers, Jessica
Schultz, Johan
Andersson, Martin
Markova, Natalia
Marttila, Petra http://orcid.org/0000-0002-0115-8067
Kim, Baek
Norin, Martin
Olin, Thomas
Helleday, Thomas
Article History
Received: 9 February 2018
Accepted: 24 August 2018
First Online: 24 September 2018
Competing interests
: Kancera AB is developing PFKFB3 inhibitors commercially for treatment of cancer. N.G., K.F., A.H.N., J.S., J.L., C.N., M.N., and T.O. are employed at Kancera AB.